Iron-saturated lactoferrin and pathogenic protozoa: Could this protein be an iron source for their parasitic style of life?

Future Microbiology

Volumn 7, Issue 1, 2012, Pages 149-164

  Ortíz Estrada, Guillermo ^a   Luna Castro, Sarahí ^a   Piña Vázquez, Carolina ^a   Samaniego Barrón, Luisa ^a   León Sicairos, Nidia ^b,c   Serrano Luna, Jesús ^a   De La Garza, Mireya ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b Departamento de Investigacin   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE SINALOA   (Mexico)

Author keywords

ferric reductase; iron; lactoferrin; lactoferrin proteases; lactoferrin binding proteins; parasites; xenosiderophores

Indexed keywords

DAPHNETIN; DEFEROXAMINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IRON; LACTOFERRIN; SIDEROPHORE;

AFRICAN TRYPANOSOMIASIS; AMEBIASIS; CONGENITAL TOXOPLASMOSIS; DIARRHEA; ENCEPHALITIS; ENDOCYTOSIS; ENDOMETRITIS; ENTAMOEBA HISTOLYTICA; GIARDIA LAMBLIA; HUMAN; INFERTILITY; IRON ABSORPTION; IRON CHELATION; IRON STORAGE; LEISHMANIA; LEISHMANIA CHAGASI; LEISHMANIASIS; MACROPHAGE; MALABSORPTION; MUCUS SECRETION; NEUTROPHIL; NONHUMAN; PARASITE SURVIVAL; PARASITE TRANSMISSION; PARASITISM; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PNEUMONIA; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTOZOON; REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; TRITRICHOMONAS FOETUS; TRYPANOSOMA BRUCEI; UTERINE CERVIX MUCOSA;

ANIMALS; ENTAMOEBA HISTOLYTICA; HOST-PARASITE INTERACTIONS; HUMANS; IRON; LACTOFERRIN; PROTOZOAN INFECTIONS; TRICHOMONAS;

ENTAMOEBA HISTOLYTICA; MAMMALIA; PROTOZOA; TOXOPLASMA GONDII; TRICHOMONAS VAGINALIS; TRITRICHOMONAS;

EID: 84555190766     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.140     Document Type: Review

References (156)

1. Lambert H, Barragan A. Modelling parasite dissemination: host cell subversion and immune evasion by Toxoplasma gondii. Cell. Microbiol. 12(3), 292-300 (2010).
2. Burchmore RJ, Barrett MP. Life in vacuoles-nutrient acquisition by Leishmania amastigotes. Int. J. Parasitol. 31(12), 1311-1320 (2001). (Pubitemid 32868711)
3. Landfear SM. Nutrient transport and pathogenesis in selected parasitic protozoa. Eukaryot. Cell 10(4), 483-493 (2011).
4. Ronnebaumer K, Gross U, Bohne W. The nascent parasitophorous vacuole membrane of Encephalitozoon cuniculi is formed by host cell lipids and contains pores which allow nutrient uptake. Eukaryot. Cell 7(6), 1001-1008 (2008). (Pubitemid 351961579)
5. Blume M, Rodriguez-Contreras D, Landfear S et al. Host-derived glucose and its transporter in the obligate intracellular pathogen Toxoplasma gondii are dispensable by glutaminolysis. Proc. Natl Acad. Sci. USA 106(31), 12998-13003 (2009).
6. Azema L, Claustre S, Alric I et al. Interaction of substituted hexose analogues with the Trypanosoma brucei hexose transporter. Biochem. Pharmacol. 67(3), 459-467 (2004). (Pubitemid 38232886)
7. Bannister LH, Hopkins JM, Fowler RE, Krishna S, Mitchell GH. A brief illustrated guide to the ultrastructure of Plasmodium falciparum asexual blood stages. Parasitol. Today 16(10), 427-433 (2000).
8. Sacks DL. Leishmaniasand fy interactions controlling species-specifc vector competence. Cell. Microbiol. 3(4), 189-196 (2001). (Pubitemid 32303353)
9. Macedo AM, Machado CR, Oliveira RP, Pena SD. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. Mem. Inst. Oswaldo Cruz 99(1), 1-12 (2004). (Pubitemid 38406258)
10. Lodge R, Descoteaux A. Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania. Clin. Immunol. 114(3), 256-265 (2005). (Pubitemid 40255131)
11. Carvalho S, Cruz T, Santarem N, Castro H, Costa V, Tomas AM. Heme as a source of iron to Leishmania infantum amastigotes. Acta Trop. 109(2), 131-135 (2009).
12. Garcia ES, Ratcliffe NA, Whitten MM, Gonzalez MS, Azambuja P. Exploring the role of insect host factors in the dynamics of Trypanosoma cruzi-Rhodnius prolixus interactions. J. Insect. Physiol. 53(1), 11-21 (2007). (Pubitemid 46027085)
13. Simpson AG, Stevens JR, Lukes J. The evolution and diversity of kinetoplastid fagellates. Trends Parasitol. 22(4), 168-174 (2006).
14. Ueno N, Bratt CL, Rodriguez NE, Wilson ME. Differences in human macrophage receptor usage, lysosomal fusion kinetics and survival between logarithmic and metacyclic Leishmania infantum chagasi promastigotes. Cell. Microbiol. 11(12), 1827-1841 (2009).
15. Felleisen RS. Host-parasite interaction in bovine infection with Tritrichomonas fetus. Microbes. Infect. 1(10), 807-816 (1999).
16. Sibley LD. Invasion and intracellular survival by protozoan parasites. Immunol. Rev. 240(1), 72-91 (2011).
17. Dunn LL, Rahmanto YS, Richardson DR. Iron uptake and metabolism in the new millennium. Trends Cell Biol. 17(2), 93-100 (2007). (Pubitemid 46199183)
18. Zhang AS, Enns CA. Iron homeostasis: recently identifed proteins provide insight into novel control mechanisms. J. Biol. Chem. 284(2), 711-715 (2009).
19. Nadadur SS, Srirama K, Mudipalli A. Iron transport & homeostasis mechanisms: their role in health & disease. Indian J. Med. Res. 128(4), 533-544 (2008).
20. Goswami T, Rolfs A, Hediger MA. Iron transport: emerging roles in health and disease. Biochem. Cell Biol. 80(5), 679-689 (2002). (Pubitemid 36124826)
21. Weinberg ED. Iron and susceptibility to infectious disease. Science 184(140), 952-956 (1974).
22. Vanacova S, Rasoloson D, Razga J, Hrdy I, Kulda J, Tachezy J. Iron-induced changes in pyruvate metabolism of Tritrichomonas fetus and involvement of iron in expression of hydrogenosomal proteins. Microbiology 147(Pt 1), 53-62 (2001). (Pubitemid 32094309)
23. Tachezy J. More on iron acquisition by parasitic protozoa. Parasitol. Today 15(5), 207 (1999). (Pubitemid 29222741)
24. Weinberg ED. Infection and iron metabolism. Am. J. Clin. Nutr. 30(9), 1485-1490 (1977). (Pubitemid 8194232)
25. Weinberg ED. Iron, infection, and neoplasia. Clin. Physiol. Biochem. 4(1), 50-60 (1986). (Pubitemid 16147216)
26. Schaible UE, Kaufmann SH. Iron and microbial infection. Nat. Rev. Microbiol. 2(12), 946-953 (2004). (Pubitemid 39562533)
27. Ratledge C. Iron metabolism and infection. Food Nutr. Bull. 28(Suppl. 4), S515-S523 (2007). (Pubitemid 351149502)
28. Weinberg ED. Iron availability and infection. Biochim. Biophys. Acta 1790(7), 600-605 (2009).
29. Baker EN, Baker HM. Molecular structure, binding properties and dynamics of lactoferrin. Cell. Mol. Life Sci. 62(22), 2531-2539 (2005). (Pubitemid 41721228)
30. Lambert LA. Molecular evolution of the transferrin family and associated receptors. Biochim. Biophys. Acta doi:10.1016/j. bbagen.2011.06.002 (2011) (Epub ahead of print).
31. Legrand D, Pierce A, Elass E, Carpentier M, Mariller C, Mazurier J. Lactoferrin structure and functions. Adv. Exp. Med. Biol. 606, 163-194 (2008).
32. van Veen HA, Geerts ME, van Berkel PH, Nuijens JH. The role of N-linked glycosylation in the protection of human and bovine lactoferrin against tryptic proteolysis. Eur. J. Biochem. 271(4), 678-684 (2004). (Pubitemid 38250910)
33. Öztas YE, Özgünes N. Lactoferrin: a multifunctional protein. Adv. Mol. Med. 1(4), 149-154 (2005).
34. Britton JR, Koldovsky O. Gastric luminal digestion of lactoferrin and transferrin by preterm infants. Early Hum. Dev. 19(2), 127-135 (1989). (Pubitemid 19137107)
35. Bullen JJ. The signifcance of iron in infection. Rev. Infect. Dis. 3(6), 1127-1138 (1981).
36. Elass E, Masson M, Mazurier J, Legrand D. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect. Immun. 70(4), 1860-1866 (2002). (Pubitemid 34245400)
37. Leon-Sicairos N, Lopez-Soto F, Reyes-Lopez M, Godinez-Vargas D, Ordaz-Pichardo C, de la Garza M. Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme. Clin. Med. Res. 4(2), 106-113 (2006). (Pubitemid 44047363)
38. Leitch EC, Willcox MD. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J. Med. Microbiol. 48(9), 867-871 (1999). (Pubitemid 29476423)
39. Vaerman JP. Effector mechanisms of IgA. Ann. Biol. Clin. (Paris) 42(1), 61-70 (1984).
40. Venkatesh MP, Rong L. Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis. J. Med. Microbiol. 57(Pt 9), 1113-1121 (2008).
41. Diarra MS, Petitclerc D, Lacasse P. Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis. J. Dairy Sci. 85(5), 1141-1149 (2002). (Pubitemid 38583363)
42. van der Strate BW, De Boer FM, Bakker HI, Meijer DK, Molema G, Harmsen MC. Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro. Antiviral Res. 58(2), 159-165 (2003). (Pubitemid 36559610)
43. Leon-Sicairos N, Reyes-Lopez M, Ordaz-Pichardo C, de la Garza M. Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica. Biochem. Cell Biol. 84(3), 327-336 (2006). (Pubitemid 44341307)
44. Dzitko K, Dziadek B, Dziadek J, Dlugonska H. Toxoplasma gondii: inhibition of the intracellular growth by human lactoferrin. Pol. J. Microbiol. 56(1), 25-32 (2007). (Pubitemid 46814167)
45. Ikadai H, Tanaka T, Shibahara N et al. Inhibitory effect of lactoferrin on in vitro growth of Babesia caballi. Am. J. Trop. Med. Hyg. 73(4), 710-712 (2005). (Pubitemid 41446718)
46. Ochoa TJ, Chea-Woo E, Campos M et al. Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clin. Infect. Dis. 46(12), 1881-1883 (2008).
47. Carruthers VB. Armed and dangerous: Toxoplasma gondii uses an arsenal of secretory proteins to infect host cells. Parasitol. Int. 48(1), 1-10 (1999). (Pubitemid 29158920)
48. Martin S. Congenital toxoplasmosis. Neonatal Netw. 20(4), 23-30 (2001).
49. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 363(9425), 1965-1976 (2004). (Pubitemid 38759657)
50. Lingelbach K, Joiner KA. The parasitophorous vacuole membrane surrounding Plasmodium and Toxoplasma: an unusual compartment in infected cells. J. Cell Sci. 111(Pt 11), 1467-1475 (1998). (Pubitemid 28288819)
51. Coppens I, Joiner KA. Parasitehost cell interactions in toxoplasmosis: new avenues for intervention? Exp. Rev. Mol. Med. 2001, 1-20 (2001).
52. Bradley PJ, Ward C, Cheng SJ et al. Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J. Biol. Chem. 280(40), 34245-34258 (2005). (Pubitemid 41443150)
53. Flanagan JL, Willcox MD. Role of lactoferrin in the tear flm. Biochimie 91(1), 35-43 (2009).
54. Dziadek B, Dzitko K, Dlugonska H. Toxoplasma gondii binds human lactoferrin but not transferrin. Exp. Parasitol. 110(2), 165-167 (2005). (Pubitemid 40693486)
55. Dziadek B, Dziadek J, Dlugonska H. Identifcation of Toxoplasma gondii proteins binding human lactoferrin: a new aspect of rhoptry proteins function. Exp. Parasitol. 115(3), 277-282 (2007). (Pubitemid 44828067)
56. Pomel S, Luk FC, Beckers CJ. Host cell egress and invasion induce marked relocations of glycolytic enzymes in Toxoplasma gondii. tachyzoites PLoS Pathog. 4(10), E1000188 (2008).
57. Espinosa-Cantellano M, Martinez-Palomo A. Pathogenesis of intestinal amebiasis: from molecules to disease. Clin. Microbiol. Rev. 13(2), 318-331 (2000). (Pubitemid 30205429)
58. +-dependent alcohol dehydrogenase in Entamoeba histolytica trophozoites. J. Parasitol. 88(2), 217-222 (2002). (Pubitemid 34493383)
59. Mehlotra RK. Antioxidant defense mechanisms in parasitic protozoa. Crit. Rev. Microbiol. 22(4), 295-314 (1996). (Pubitemid 27014395)
60. Ali V, Nozaki T. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites. Clin. Microbiol. Rev. 20(1), 164-187 (2007). (Pubitemid 46167772)
61. Loftus B, Anderson I, Davies R et al. The genome of the protist parasite Entamoeba histolytica. Nature 433(7028), 865-868 (2005). (Pubitemid 40314894)
62. Wassmann C, Hellberg A, Tannich E, Bruchhaus I. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and favin reductase. J. Biol. Chem. 274(37), 26051-26056 (1999).
63. Murray MJ, Murray A, Murray CJ. The salutary effect of milk on amoebiasis and its reversal by iron. Br. Med. J. 280(6228), 1351-1352 (1980). (Pubitemid 10124275)
64. Diamond LS, Harlow DR, Cunnick CC. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba Trans. R. Soc. Trop. Med. Hyg. 72(4), 431-432 (1978). (Pubitemid 8389164)
65. Leon-Sicairos N, Reyes-Lopez M, Canizalez-Roman A et al. Human hololactoferrin: endocytosis and use as an iron source by the parasite Entamoeba histolytica. Microbiology 151(Pt 12), 3859-3871 (2005). (Pubitemid 41829967)
66. Reyes-Lopez M, Leon-Sicairos N, Canizalez-Roman A, Pérez-Ramos J, De la Garza M. Vesicular traffc of human holo-transferrin and holo-lactoferrin in Entamoeba histolytica. Presented at: IXth International Conference on Lactoferrin, Structure Function & Applications. Beijing, China, 18-22 October 2009.
67. Prentice A, MacCarthy A, Stirling DM, Vasquez-Velasquez L, Ceesay SM. Breast-milk IgA and lactoferrin survival in the gastrointestinal tract-a study in rural Gambian children. Acta Paediatr. Scand. 78(4), 505-512 (1989). (Pubitemid 19218294)
68. Ortíz-Estrada G, Luna-Castro S, Piña-Vázquez C, de la Garza M. The parasite Entamoeba histolytica binds bovine holo-lactoferrin with high affnity and uses this protein as an iron source. Presented at: The Xth International Conference on Lactoferrin: Structure, Function and Applications (X ILC). Mazatlán, México, 8-12 May 2011.
69. Manning K. Update on the diagnosis and management of Tritrichomonas fetus infections in cats. Top. Companion Anim. Med. 25(3), 145-148 (2010).
70. Pereira-Neves A, Campero CM, Martinez A, Benchimol M. Identifcation of Tritrichomonas fetus pseudocysts in fresh preputial secretion samples from bulls. Vet. Parasitol. 175(1-2), 1-8 (2011).
71. Gookin JL, Breitschwerdt EB, Levy MG, Gager RB, Benrud JG. Diarrhea associated with trichomonosis in cats. J. Am. Vet. Med. Assoc. 215(10), 1450-1454 (1999).
72. Lun ZR, Chen XG, Zhu XQ, Li XR, Xie MQ. Are Tritrichomonas fetus and Tritrichomonas suis synonyms? Trends Parasitol. 21(3), 122-125 (2005).
73. Tachezy J, Kulda J, Bahnikova I, Suchan P, Razga J, Schrevel J. Tritrichomonas fetus: iron acquisition from lactoferrin and transferrin. Exp. Parasitol. 83(2), 216-228 (1996). (Pubitemid 26274070)
74. Kulda J, Poislova M, Suchan P, Tachezy J. Iron enhancement of experimental infection of mice by Tritrichomonas fetus. Parasitol. Res. 85(8-9), 692-699 (1999). (Pubitemid 29304931)
75. Rao KS, Roberts TK, Masson PL, Heremans JF. Lactoferrin, a major soluble protein of bovine oestrous cervical mucus. J. Reprod. Fertil. 32(1), 89-92 (1973).
76. Wilson ME, Vorhies RW, Andersen KA, Britigan BE. Acquisition of iron from transferrin and lactoferrin by the protozoan Leishmania chagasi. Infect. Immun. 62(8), 3262-3269 (1994). (Pubitemid 24232109)
77. Jarosik GP, Land CB, Duhon P, Chandler R Jr, Mercer T. Acquisition of iron by Gardnerella vaginalis. Infect. Immun. 66(10), 5041-5047 (1998). (Pubitemid 28453119)
78. Suchan P, Vyoral D, Petrak J et al. Incorporation of iron into Tritrichomonas fetus cell compartments reveals ferredoxin as a major iron-binding protein in hydrogenosomes. Microbiology 149(Pt 7), 1911-1921 (2003). (Pubitemid 36874336)
79. Peterson KM, Alderete JF. Iron uptake and increased intracellular enzyme activity follow host lactoferrin binding by Trichomonas vaginalis receptors. J. Exp. Med. 160(2), 398-410 (1984). (Pubitemid 14052505)
80. Lehker MW, Alderete JF. Iron regulates growth of Trichomonas vaginalis and the expression of immunogenic trichomonad proteins. Mol. Microbiol. 6(1), 123-132 (1992).
81. Grab DJ, Lonsdale-Eccles JD, Oli MW, Corbeil LB. Lactoferrin-binding proteins of Tritrichomonas fetus. J. Parasitol. 87(5), 1064-1070 (2001).
82. Affonso AL, Benchimol M, Ribeiro KC, Lins U, De Souza W. Further studies on the endocytic activity of Tritrichomonas fetus. Parasitol. Res. 80(5), 403-413 (1994). (Pubitemid 24236980)
83. Pierce A, Colavizza D, Benaissa M et al. Molecular cloning and sequence analysis of bovine lactotransferrin. Eur. J. Biochem. 196(1), 177-184 (1991).
84. Affonso AL, de Almeida JC, Benchimol M. Partial characterization of cytoplasmic compartments involved in the endocytic process of Tritrichomonas fetus. Eur. J. Cell Biol. 72(3), 247-256 (1997). (Pubitemid 27117131)
85. Neutra MR, Ciechanover A, Owen LS, Lodish HF. Intracellular transport of transferrin-and asialoorosomucoid-colloidal gold conjugates to lysosomes after receptor-mediated endocytosis. J. Histochem. Cytochem. 33(11), 1134-1144 (1985). (Pubitemid 16207170)
86. Aisen P, Leibman A. Lactoferrin and transferrin: a comparative study. Biochim. Biophys. Acta 257(2), 314-323 (1972).
87. Mazurier J, Spik G. Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim. Biophys. Acta 629(2), 399-408 (1980). (Pubitemid 10090979)
88. Tachezy J, Suchan P, Schrevel J, Kulda J. The host-protein-independent iron uptake by Tritrichomonas fetus. Exp. Parasitol. 90(2), 155-163 (1998). (Pubitemid 28471918)
89. Hayer A, Stoeber M, Bissig C, Helenius A. Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes. Traffc 11(3), 361-382 (2010).
90. Ivanov AI. Pharmacological inhibition of endocytic pathways: is it specifc enough to be useful? Methods Mol. Biol. 440, 15-33 (2008).
91. Ciechanover A, Schwartz AL, Dautry-Varsat A, Lodish HF. Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents. J. Biol. Chem. 258(16), 9681-9689 (1983). (Pubitemid 13049101)
92. Talbot JA, Nielsen K, Corbeil LB. Cleavage of proteins of reproductive secretions by extracellular proteinases of Tritrichomonas fetus. Can. J. Microbiol. 37(5), 384-390 (1991).
93. Kassai T, Cordero del Campillo M, Euzeby J, Gaafar S, Hiepe T, Himonas CA. Standardized nomenclature of animal parasitic diseases (SNOAPAD). Vet. Parasitol. 29(4), 299-326 (1988).
94. Cotch MF, Pastorek JG 2nd, Nugent RP, Yerg DE, Martin DH, Eschenbach DA. Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The vaginal infections and prematurity study group. Obstet. Gynecol. 78(6), 1087-1092 (1991).
95. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodefciency virus infection and other sexually transmitted diseases. Sex Transm. Dis. 19(2), 61-77 (1992). (Pubitemid 23101885)
96. Laga M, Manoka A, Kivuvu M et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7(1), 95-102 (1993). (Pubitemid 23069039)
97. Lehker MW, Chang TH, Dailey DC, Alderete JF. Specifc erythrocyte binding is an additional nutrient acquisition system for Trichomonas vaginalis. J. Exp. Med. 171(6), 2165-2170 (1990). (Pubitemid 20200253)
98. Gorrell TE. Effect of culture medium iron content on the biochemical composition and metabolism of Trichomonas vaginalis. J. Bacteriol. 161(3), 1228-1230 (1985). (Pubitemid 15138559)
99. Cohen MS, Britigan BE, French M, Bean K. Preliminary observations on lactoferrin secretion in human vaginal mucus: variation during the menstrual cycle, evidence of hormonal regulation, and implications for infection with Neisseria gonorrhoeae. Am. J. Obstet. Gynecol. 157(5), 1122-1125 (1987). (Pubitemid 17163781)
100. Kristjanson PM, Swallow BM, Rowlands GJ, Kruska RL, de Leeuw PN. Measuring the costs of African animal trypanosomosis, the potential benefts of control and returns to research. Agricultural Syst. 59(1), 79-98 (1999). (Pubitemid 29107430)
101. Peacock L, Ferris V, Sharma R et al. Identifcation of the meiotic life cycle stage of Trypanosoma brucei in the tsetse fy. Proc. Natl Acad. Sci. USA 108(9), 3671-3676 (2011).
102. Breidbach T, Scory S, Krauth-Siegel RL, Steverding D. Growth inhibition of bloodstream forms of Trypanosoma brucei by the iron chelator deferoxamine. Int. J. Parasitol. 32(4), 473-479 (2002). (Pubitemid 34159133)
103. Steverding D. Bloodstream forms of Trypanosoma brucei require only small amounts of iron for growth. Parasitol. Res. 84(1), 59-62 (1998). (Pubitemid 28097627)
104. Schell D, Borowy NK, Overath P. Transferrin is a growth factor for the bloodstream form of Trypanosoma brucei. Parasitol. Res. 77(7), 558-560 (1991).
105. Tanaka T, Abe Y, Inoue N et al. The detection of bovine lactoferrin binding protein on Trypanosoma brucei. J. Vet. Med. Sci. 66(6), 619-625 (2004). (Pubitemid 41380280)
106. Lama A, Kucknoor A, Mundodi V, Alderete JF. Glyceraldehyde-3-phosphate dehydrogenase is a surface-associated, fbronectin-binding protein of Trichomonas vaginalis. Infect. Immun. 77(7), 2703-2711 (2009).
107. Reyes-Lopez M, Bermudez-Cruz RM, Avila EE, de la Garza M. Acetaldehyde/alcohol dehydrogenase-2 (EhADH2) and clathrin are involved in internalization of human transferrin by Entamoeba histolytica. Microbiology 157(Pt 1), 209-219 (2011).
108. Modun B, Williams P. The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase. Infect. Immun. 67(3), 1086-1092 (1999). (Pubitemid 29108481)
109. Ankarklev J, Jerlstrom-Hultqvist J, Ringqvist E, Troell K, Svard SG. Behind the smile: cell biology and disease mechanisms of Giardia species. Nat. Rev. Microbiol. 8(6), 413-422 (2010).
110. Thompson RC. Giardiasis as a re-emerging infectious disease and its zoonotic potential. Int. J. Parasitol. 30(12-13), 1259-1267 (2000).
111. Eckmann L. Mucosal defences against Giardia. Parasite Immunol. 25(5), 259-270 (2003). (Pubitemid 38021456)
112. Multigner L, Figarella C, Sarles H. Diagnosis of chronic pancreatitis by measurement of lactoferrin in duodenal juice. Gut 22(5), 350-354 (1981). (Pubitemid 11086931)
113. Brugge WR, Burke CA. Lactoferrin secretion in alcoholic pancreatic disease. Dig. Dis. Sci. 33(2), 178-184 (1988). (Pubitemid 18054680)
114. Wilkin A, Feinberg J. Pneumocystis carinii pneumonia: a clinical review. Am. Fam. Physician. 60(6), 1699-1708, 1713-1714 (1999).
115. Castro M. Treatment and prophylaxis of Pneumocystis carinii pneumonia. Semin. Respir. Infect. 13(4), 296-303 (1998). (Pubitemid 28560097)
116. Morris A, Beard CB, Huang L. Update on the epidemiology and transmission of Pneumocystis carinii. Microbes Infect. 4(1), 95-103 (2002). (Pubitemid 34127996)
117. Clarkson AB Jr, Saric M, Grady RW. Deferoxamine and efornithine (DL-a-difuoromethylornithine) in a rat model of Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 34(9), 1833-1835 (1990). (Pubitemid 20259530)
118. Weinberg GA. Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob. Agents Chemother. 38(5), 997-1003 (1994). (Pubitemid 24150828)
119. Clarkson AB Jr, Turkel-Parrella D, Williams JH, Chen LC, Gordon T, Merali S. Action of deferoxamine against Pneumocystis carinii. Antimicrob. Agents Chemother. 45(12), 3560-3565 (2001). (Pubitemid 33107878)
120. Weinberg GA, Shaw MM. Suppressive effect of deferoxamine on the growth of Pneumocystis carinii in vitro. J. Protozool. 38(6), S223-S224 (1991).
121. Ye B, Zheng YQ, Wu WH, Zhang J. Iron chelator daphnetin against Pneumocystis carinii in vitro. Chin. Med. J. (Engl.) 117(11), 1704-1708 (2004). (Pubitemid 39619250)
122. Mateos F, Gonzalez C, Dominguez C, Losa JE, Jimenez A, Perez-Arellano JL. Elevated non-transferrin bound iron in the lungs of patients with Pneumocystis carinii pneumonia. J. Infect. 38(1), 18-21 (1999). (Pubitemid 29082011)
123. Testa U. Lactoferrin. In: Proteins of Iron Metabolism. Testa U (Ed.). CRS Press, Boca Raton, FL, USA, 71-141 (2002).
124. Marquis JF, Gros P. Intracellular Leishmania: your iron or mine? Trends Microbiol. 15(3), 93-95 (2007). (Pubitemid 46356977)
125. Anstead GM, Chandrasekar B, Zhao W, Yang J, Perez LE, Melby PC. Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect. Immun. 69(8), 4709-4718 (2001). (Pubitemid 32674447)
126. Kaye P, Scott P. Leishmaniasis: complexity at the host-pathogen interface. Nat. Rev. Microbiol. 9(8), 604-615 (2011).
127. Courret N, Frehel C, Prina E, Lang T, Antoine JC. Kinetics of the intracellular differentiation of Leishmania amazonensis and internalization of host MHC molecules by the intermediate parasite stages. Parasitology 122(Pt 3), 263-279 (2001). (Pubitemid 32234871)
128. Courret N, Frehel C, Gouhier N et al. Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites. J. Cell Sci. 115(Pt 11), 2303-2316 (2002). (Pubitemid 34752974)
129. Olivier M, Gregory DJ, Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18(2), 293-305 (2005). (Pubitemid 40548295)
130. Forbes JR, Gros P. Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol. 9(8), 397-403 (2001). (Pubitemid 32763067)
131. Huynh C, Andrews NW. Iron acquisition within host cells and the pathogenicity of Leishmania. Cell. Microbiol. 10(2), 293-300 (2008).
132. Okujo N, Akiyama T, Miyoshi S, Shinoda S, Yamamoto S. Involvement of vulnibactin and exocellular protease in utilization of transferrin-and lactoferrin-bound iron by Vibrio vulnifcus. Microbiol. Immunol. 40(8), 595-598 (1996). (Pubitemid 26282114)
133. Wilson ME, Lewis TS, Miller MA, McCormick ML, Britigan BE. Leishmania chagasi: uptake of iron bound to lactoferrin or transferrin requires an iron reductase. Exp. Parasitol. 100(3), 196-207 (2002). (Pubitemid 36269038)
134. Flannery AR, Huynh C, Mittra B, Mortara RA, Andrews N W. LFR1 ferric iron reductase of Leishmania amazonensis is essential for the generation of infective parasite forms. J. Biol. Chem. 286(26), 23266-23279 (2011).
135. Weinberg ED. Microbial pathogens with impaired ability to acquire host iron. Biometals 13(1), 85-89 (2000). (Pubitemid 30243040)
136. Wilson ME, Britigan BE. Iron acquisition by parasitic protozoa. Parasitol. Today 14(9), 348-353 (1998). (Pubitemid 28374965)
137. Brown JS, Holden DW. Iron acquisition by Gram-positive bacterial pathogens. Microbes Infect. 4(11), 1149-1156 (2002). (Pubitemid 35279522)
138. Sutak R, Chamot C, Tachezy J, Camadro JM, Lesuisse E. Siderophore and haem iron use by Tritrichomonas fetus. Microbiology 150(Pt 12), 3979-3987 (2004). (Pubitemid 40045327)
139. Rodriguez C, Cofre JV, Sanchez M, Fernandez P, Boggiano G, Castro E. Lactobacilli isolated from vaginal vault of dairy and meat cows during progesteronic stage of estrous cycle. Anaerobe 17(1), 15-18 (2011).
140. Otero C, Saavedra L, Silva de Ruiz C, Wilde O, Holgado AR, Nader-Macias ME. Vaginal bacterial microfora modifcations during the growth of healthy cows. Lett. Appl. Microbiol. 31(3), 251-254 (2000).
141. Wesselius LJ, Williams WL, Bailey K, Vamos S, O'Brien-Ladner AR, Wiegmann T. Iron uptake promotes hyperoxic injury to alveolar macrophages. Am. J. Respir. Crit. Care Med. 159(1), 100-106 (1999). (Pubitemid 29036510)
142. Bennett RM, Kokocinski T. Lactoferrin content of peripheral blood cells. Br. J. Haematol. 39(4), 509-521 (1978). (Pubitemid 8398734)
143. Kolsto Otnaess AB, Meberg A, Sande HA. Plasma lactoferrin measured by an enzyme-linked immunosorbent assay (ELISA). Measurements on adult and infant plasma. Scand. J. Haematol. 31(3), 235-240 (1983). (Pubitemid 13038362)
144. Qin Y, Zhu W, Zhan C et al. Investigation on positive correlaztion of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2' mapping. J. Huazhong Univ. Sci. Technolog. Med. Sci. 31(4), 578-585 (2011).
145. Fahy JV, Steiger DJ, Liu J, Basbaum CB, Finkbeiner WE, Boushey HA. Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects. Am. Rev. Respir. Dis. 147(5), 1132-1137 (1993). (Pubitemid 23149868)
146. Talukder MJ, Takeuchi T, Harada E. Transport of colostral macromolecules into the cerebrospinal fuid via plasma in newborn calves. J. Dairy Sci. 85(3), 514-524 (2002). (Pubitemid 38572269)
147. Romaris EM, Cervantes II, Lopez JM, Marcen JF. Concentration of calcium and magnesium and trace elements (zinc, copper, iron and manganese) in cerebrospinal fuid: a try of a pathophysiological classifcation. J. Trace Elem. Med. Biol. 25(Suppl. 1), S45-S49 (2011).
148. Pandey S, Chowdhury AR, Tewari SR, Kamboj V P. Trace elements in cervical mucus of infertile women. Indian J. Med. Res. 84, 163-166 (1986). (Pubitemid 17171049)
149. Tauber PF, Zaneveld LJ, Propping D, Schumacher GF. Components of human split ejaculates. I. Spermatozoa, fructose, immunoglobulins, albumin, lactoferrin, transferrin and other plasma proteins. J. Reprod. Fertil. 43(2), 249-267 (1975).
150. Allgood J W, Brown EB. The relationship between duodenal mucosal iron concentration and iron absorption in human subjects. Scand. J. Haematol. 4(3), 217-229 (1967).
151. Kijlstra A, Jeurissen SH, Koning KM. Lactoferrin levels in normal human tears. Br. J. Ophthalmol. 67(3), 199-202 (1983). (Pubitemid 13144022)
152. Kayazawa M, Saitoh O, Kojima K et al. Lactoferrin in whole gut lavage fuid as a marker for disease activity in infammatory bowel disease: comparison with other neutrophil-derived proteins. Am. J. Gastroenterol. 97(2), 360-369 (2002). (Pubitemid 34160762)
153. Sidhu R, Wilson P, Wright A et al. Faecal lactoferrin-a novel test to differentiate between the irritable and infamed bowel? Aliment Pharmacol. Ther. 31(12), 1365-1370 (2010).
154. Niemela A, Kulomaa M, Vija P, Tuohimaa P, Saarikoski S. Lactoferrin in human amniotic fuid. Hum. Reprod. 4(1), 99-101 (1989).
155. Evans P, Cindrova-Davies T, Muttukrishna S, Burton GJ, Porter J, Jauniaux E. Hepcidin and iron species distribution inside the frst-trimester human gestational sac. Mol. Hum. Reprod. 17(4), 227-232 (2011).
156. Tanaka T, Abe Y, Kim WS et al. The detection of bovine lactoferrin binding protein on Toxoplasma gondii. J. Vet. Med. Sci. 65(12), 1377-1380 (2003). (Pubitemid 41365443)